机译:Obinutuzumab does not improve complete methabolic response but does not compromise mobilization or engraftment of autologous peripheral blood stem cells in diffuse large B cell lymphoma: Results from a fondazione italiana linfomi prospective phase II study (the GIOTTO study)
UOC Hematology and Stem Cell Transplantation,AO San Camillo Forlanini;
SOD Hematology,AOU Careggi;
Unit of Clinical EpidemiologyPoliclinico San Matteo Pavia Fondazione IRCCSInstitute of HematologyHematology UnitDivision of Hematology and BMTDepartment of Cellular Biotechnologies and Hematology,Hematology UnitFondazione Italiana Linfomi ONLUSUOSD Ematologia e TrapiantiUOC EmatologiaUOC Ematologia dell'Ospedale dell'Angelo;